Medicis used to have the US marketing rights to Dysport for cosmetic indications, and even their top-flight salesforce could not make much headway. The problem was (and is) that Dysport is not as good a product as Botox.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”